Interferon lambda inhibits dengue virus replication in epithelial cells

Area of Science:

• Virology
• Immunology
• Cell Biology

Background:

• Dengue virus (DENV) evades the host's type I interferon (IFN-I) antiviral response.
• Type III interferon (IFN-λ) offers a complementary antiviral pathway.
• This study investigates the role of IFN-λ against DENV-2 infection.

Purpose of the Study:

• To analyze the IFN-λ mediated antiviral response against DENV-2.
• To assess IFN-λ levels in dengue fever patients.
• To evaluate the efficacy of IFN-λ in an in vitro model of DENV infection.

Main Methods:

• ELISA was used to measure serum IFN-λ levels in dengue patients and healthy donors.
• An epithelial cell line (C33-A) permissive to DENV-2 was utilized for in vitro studies.
• RT-qPCR measured the expression of IFN-stimulated genes (ISGs) and SOCS genes.

Main Results:

• Dengue patients exhibited approximately 1.8 times higher serum IFN-λ levels than healthy individuals.
• IFN-λ demonstrated dose-dependent inhibition of DENV-2 replication in vitro.
• Increased ISG expression (MX1, OAS1) correlated with viral inhibition; SOCS1/3 presence was linked to reduced IFN-λ1 expression.

Conclusions:

• IFN-λ is a potential candidate for inhibiting viral replication in dengue infections.
• Further research into DENV-IFN-λ interactions could reveal new treatment strategies.
• A novel epithelial cell model for studying dengue infection in vitro was established.